These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3216232)

  • 21. [The value of gadolinium-DTPA in the study of the urinary bladder].
    Beyer HK; Blümm R; Hötzinger H
    Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
    [No Abstract]   [Full Text] [Related]  

  • 22. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.
    Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW
    Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance contrast media for myocardial imaging.
    Higgins CB; Saeed M; Wendland MF
    Invest Radiol; 1990 Sep; 25 Suppl 1():S74. PubMed ID: 2283265
    [No Abstract]   [Full Text] [Related]  

  • 24. [Enteral MRI contrast media--advances in magnetic resonance tomography of the abdomen and pelvis].
    Radiologe; 1994 Aug; 34(8 Suppl):1-12. PubMed ID: 9218063
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of gadolinium-DTPA-enhanced MRI to characterize renal mass in patient with renal insufficiency.
    Terens WL; Gluck R; Golimbu M; Rofsky NM
    Urology; 1992 Aug; 40(2):152-4. PubMed ID: 1502753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paramagnetic agents as tracers in magnetic resonance imaging. Extrapolations from Gd-DTPA to everything.
    Koenig SH
    Acta Radiol Suppl; 1990; 374():17-23. PubMed ID: 1966965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of MRI with Gd-DTPA in brain tumors].
    Sakamoto Y; Takahashi M; Miyawaki M; Bussaka H; Wakamatsu H
    Rinsho Hoshasen; 1988 Apr; 33(4):435-8. PubMed ID: 3398269
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid MR imaging of a vascular challenge to focal ischemia in cat brain.
    de Crespigny AJ; Wendland MF; Derugin N; Vexler ZS; Moseley ME
    J Magn Reson Imaging; 1993; 3(3):475-81. PubMed ID: 8324306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
    Vogl T; Dresel S; Schedel H; Markl A; Grevers G; Stelzer S; Lissner J
    Rofo; 1989 May; 150(5):516-22. PubMed ID: 2541475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.
    Müller TB; Haraldseth O; Jones RA; Sebastiani G; Godtliebsen F; Lindboe CF; Unsgård G
    Stroke; 1995 Mar; 26(3):451-7; discussion 457-8. PubMed ID: 7886724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of contrast media for magnetic resonance imaging.
    Goldstein HA; Wiggins JR; Kashanian F
    Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
    [No Abstract]   [Full Text] [Related]  

  • 32. Contrast agents in magnetic resonance imaging.
    Roux E; De Broe L
    J Belge Radiol; 1988; 71(1):31-6. PubMed ID: 3372466
    [No Abstract]   [Full Text] [Related]  

  • 33. Gadolinium-DTPA: a new contrast agent.
    Niendorf HP
    Bristol Med Chir J; 1988 May; 103(2):34. PubMed ID: 3219630
    [No Abstract]   [Full Text] [Related]  

  • 34. MRI monitoring of experimental cerebral ischaemia: comparison of two models.
    Forsting M; Reith W; Dörfler A; Meyding-Lamadé U; Sartor K
    Neuroradiology; 1994 May; 36(4):264-8. PubMed ID: 8065566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging of transverse myelitis using Gd-DTPA.
    Pardatscher K; Fiore DL; Lavano A
    J Neuroradiol; 1992; 19(1):63-7. PubMed ID: 1564531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 37. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
    Chisin R; Gomori JM; Elidan J
    Isr J Med Sci; 1992; 28(3-4):268-76. PubMed ID: 1592599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gd DTPA. Clinical efficacy.
    Runge VM; Schaible TF; Goldstein HA; Wood ML; Haughton VM; Maravilla KR; Weinstein MA; Price AC; Wolpert SM; Kaufman D
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute experimental cerebral ischemia: MR enhancement using Gd-DTPA.
    McNamara MT; Brant-Zawadzki M; Berry I; Pereira B; Weinstein P; Derugin N; Moore S; Kucharczyk W; Brasch RC
    Radiology; 1986 Mar; 158(3):701-5. PubMed ID: 3945743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.
    Murphy KJ; Hansen R; Prince MR
    AJR Am J Roentgenol; 1997 Jul; 169(1):318-9. PubMed ID: 9207574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.